Product Images Bosulif

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Bosulif NDC 0069-0136 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - bosulif 01

Chemical Structure - bosulif 01

Logo - bosulif 02

Logo - bosulif 02

This text is a simple statement indicating that a company named "Pfizer Labs," which is a division of "Pfizer Inc" located in NY, NY 10017, is responsible for distribution.*

Logo - bosulif 03

Logo - bosulif 03

This is a description of Pfizer Labs, which is a division of the larger pharmaceutical company Pfizer Inc. The text indicates that Pfizer Labs is responsible for distribution of products, although it does not specify what types of products are being distributed. The address provided is located in New York City.*

PRINCIPAL DISPLAY PANEL - 100 mg Bottle Label - bosulif 04

PRINCIPAL DISPLAY PANEL - 100 mg Bottle Label - bosulif 04

This text provides storage instructions along with dosage and usage information for Bosulif tablets. It indicates that the tablets should be stored in a tight, child-resistant container within a certain temperature range. The tablets contain 103.40 mg of bostinib monohydrate equivalent to 100 mg of bosutinib, and they should not be crushed or cut. The document also includes the manufacturer's details, dosage instructions, lot id, NDC number, and GTIN number.*

PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label - bosulif 05

PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label - bosulif 05

This is a prescription drug called Bosulif, which comes in the form of tablets containing 516.98mg of bosutinib monohydrate equivalent to 500mg of bosutinib. The tablets should be stored at a temperature of 20-25°C, and can be stored at temperatures between 15-30°C without affecting their efficacy. The medication should be dispensed in tight child-resistant containers. The details of dosage and use can be found in the accompanying prescribing information. Manufactured in Spain and distributed by Pfizer Labs, this drug is labelled for use in oncology and should not be crushed or cut. The text also includes information on the packaging, such as the lot number, NDC (National Drug Code), and GTIN (Global Trade Item Number).*

PRINCIPAL DISPLAY PANEL - 400 mg Tablet Bottle Label - bosulif 06

PRINCIPAL DISPLAY PANEL - 400 mg Tablet Bottle Label - bosulif 06

"Bosulif" is a medication that contains 413.60mg of bosutinib monohydrate equivalent to 400mg of bosutinib. Each tablet is distributed by Pfizer Labs Division of Pfizer Inc and should be stored at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). It is available in 30-tablet Rx only. Do not crush or cut the tablets, and see accompanying prescribing information. The medication is dispensed in tight (USP), child-resistant containers. GTIN is 00300690193014, and PAA is 078992. The Lot Number is not available. Made in Spain.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.